LOS ALTOS, Calif.--(BUSINESS WIRE)--March 1, 2005--Phage International Inc. announced today that it has entered into a definitive agreement to acquire Phage Therapy Center, Tbilisi, Republic of Georgia, a privately held medical clinic offering bacteriophage therapy to patients from across the globe, and co-developer of PhageBioderm, a revolutionary bioactive medical polymer that is utilized for treating bed sores, burns, and tropical/necrotic ulcers. As PhageBioderm biodegrades, it delivers drugs, antibiotics, or pain medications. Bacteriophages or phages are viruses that invade bacterial cells. Lytic phages disrupt bacterial metabolism and cause the bacterium to lyse. Like antibiotics, lytic phages have remarkable antibacterial activity.
